Catalyst Wire Dossier Catalyst Wire Dossier

MR-130A-01 Contraceptive Transdermal Patch

· Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR-130A-01 Contraceptive Transdermal Patch, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch [Phase 2]

See pricing